Positron emission tomography changes in PARK1 mutation
- 6 October 2005
- journal article
- Published by Wiley in Movement Disorders
- Vol. 21 (1), 127-130
- https://doi.org/10.1002/mds.20691
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The sensitivity of 18‐fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's diseaseEuropean Journal of Neurology, 2003
- Young-Onset Parkinson Disease With and Without Parkin Gene MutationsArchives of Neurology, 2003
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-β-carbomethoxy-3-β-(4-fluorophenyl)-tropane in patients with movement disordersNuclear Medicine Communications, 2002
- Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral StriatumJournal of Cerebral Blood Flow & Metabolism, 2001
- PET studies of parkinsonism associated with mutation in the α-synuclein geneNeurology, 1999
- Mutated α-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance?Neurology, 1999
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences of the United States of America, 1998
- Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region ModelNeuroImage, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997